These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 9256429)

  • 21. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
    Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
    Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
    Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of dominant negative effect of the PLZF-RARalpha against the wild-type RARalpha in acute promyelocytic leukemia].
    Dong S; Zhu J; Kuang S; Qiu J; Wang Z; Chen S; Chen L
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):8-12. PubMed ID: 15622742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two critical hits for promyelocytic leukemia.
    He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
    Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia.
    So CW; Dong S; So CK; Cheng GX; Huang QH; Chen SJ; Chan LC
    Leukemia; 2000 Jan; 14(1):77-83. PubMed ID: 10637480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of two fusion retinoic acid receptor alpha in acute promyelocytic leukemia].
    Zhong H; Dong S; Chen G; Jiang X; Xia Z; Yi N; Wang Z; Chen S; Xu Y; Chen L
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jul; 18(7):339-42. PubMed ID: 15624327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
    Hong SH; Wong CW; Privalsky ML
    Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.
    Puccetti E; Sennewald B; Fosca-Ferrara F; Boehrer S; Bianchini A; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Hematol J; 2001; 2(6):385-92. PubMed ID: 11920278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
    Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
    J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation in acute promyelocytic leukemia.
    Lin RJ; Sternsdorf T; Tini M; Evans RM
    Oncogene; 2001 Oct; 20(49):7204-15. PubMed ID: 11704848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoic acid, but not arsenic trioxide, degrades the PLZF/RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient.
    Koken MH; Daniel MT; Gianni M; Zelent A; Licht J; Buzyn A; Minard P; Degos L; Varet B; de Thé H
    Oncogene; 1999 Jan; 18(4):1113-8. PubMed ID: 10023688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.
    Lin RJ; Evans RM
    Mol Cell; 2000 May; 5(5):821-30. PubMed ID: 10882118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARalpha, resulting in sequestration and decreased mobility of SMRT.
    Huang Y; Qiu J; Chen G; Dong S
    Biochem Biophys Res Commun; 2008 Jan; 365(2):258-65. PubMed ID: 17991421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Stat5-RARalpha fusion protein represses transcription and differentiation through interaction with a corepressor complex.
    Maurer AB; Wichmann C; Gross A; Kunkel H; Heinzel T; Ruthardt M; Groner B; Grez M
    Blood; 2002 Apr; 99(8):2647-52. PubMed ID: 11929749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.
    Qiu J; Huang Y; Chen G; Chen Z; Tweardy DJ; Dong S
    Mol Biol Cell; 2007 Oct; 18(10):3941-51. PubMed ID: 17671166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT.
    Takahashi S; McConnell MJ; Harigae H; Kaku M; Sasaki T; Melnick AM; Licht JD
    Blood; 2004 Jun; 103(12):4650-8. PubMed ID: 14982881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
    Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
    Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.